Form 4 for EW Edwards Lifesciences
Accepted 2023-05-15 00:00:00 ET · period of report 2023-05-11 · accession 0001225208-23-005920 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-15 | 2023-05-11 | EW | SELLERS ROBERT W.A. | SVP, Corp. Ctrl | A - Grant | $0.00 | +1,800 | 13.0K | +16% | $0 |
| D | 2023-05-15 | 2023-05-11 | EW | SELLERS ROBERT W.A. | SVP, Corp. Ctrl | A - Grant | $0.00 | +5,540 | 5,540 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-11 | A | A | 1,800 | $0.00 | 13,035.79 | D | — | — | (F1) These restricted stock units were granted on May 11, 2023 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. |
| 2 | Derivative | Employee Stock Option (Right to Acquire) | 2023-05-11 | A | A | 5,540 | $0.00 | 5,540 | D | $88.78 · 2024-05-11 to 2030-05-10 | 5,540 Common Stock | (F2) These options were granted on May 11, 2023 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal monthly installments. |